Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125808252 | 12580825 | 2 | F | 20160503 | 20160817 | 20160721 | 20160825 | EXP | GB-MHRA-MIDB-1878CC3B-1F54-4376-A9E8-F853D8779173 | GB-MYLANLABS-2016M1029241 | MYLAN | 0.00 | Y | 0.00000 | 20160825 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125808252 | 12580825 | 1 | SS | ISOSORBIDE MONONITRATE. | ISOSORBIDE MONONITRATE | 1 | Oral | 20 MG, BID | Y | U | 0 | 20 | MG | BID | |||||
| 125808252 | 12580825 | 2 | SS | NAPROXEN. | NAPROXEN | 1 | Oral | 500 MG, BID | Y | U | 0 | 500 | MG | BID | |||||
| 125808252 | 12580825 | 3 | PS | TRAMADOL. | TRAMADOL | 1 | Oral | 50 MG, BID | U | U | 75986 | 50 | MG | BID | |||||
| 125808252 | 12580825 | 4 | C | ASPIRIN /00002701/ | ASPIRIN | 1 | Oral | 75 MG, QD (EVERY MORNING) | U | 0 | 75 | MG | QD | ||||||
| 125808252 | 12580825 | 5 | C | ATENOLOL. | ATENOLOL | 1 | Oral | 25 MG, QD (EVERY MORNING) | U | 0 | 25 | MG | QD | ||||||
| 125808252 | 12580825 | 6 | C | CYCLIZINE | CYCLIZINE | 1 | Oral | 50 MG, UNK (THREE TIMES DAILY AS NECESSARY) (AS NECESSARY) | U | 0 | 50 | MG | |||||||
| 125808252 | 12580825 | 7 | C | FERROUS SULFATE. | FERROUS SULFATE | 1 | Oral | 200 MG, BID | U | 0 | 200 | MG | BID | ||||||
| 125808252 | 12580825 | 8 | C | LEVOTHYROXINE SODIUM. | LEVOTHYROXINE SODIUM | 1 | Oral | 100 ?G, QOD (ALTERNATE DAYS) | U | 0 | 100 | UG | QOD | ||||||
| 125808252 | 12580825 | 9 | C | PARACETAMOL | ACETAMINOPHEN | 1 | Oral | 500 MG, UNK | U | 0 | 500 | MG | |||||||
| 125808252 | 12580825 | 10 | C | RAMIPRIL. | RAMIPRIL | 1 | Oral | 2.5 MG, QD | U | 0 | 2.5 | MG | QD | ||||||
| 125808252 | 12580825 | 11 | C | LAXATIVE | UNSPECIFIED INGREDIENT | 1 | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125808252 | 12580825 | 1 | Product used for unknown indication |
| 125808252 | 12580825 | 2 | Product used for unknown indication |
| 125808252 | 12580825 | 3 | Product used for unknown indication |
| 125808252 | 12580825 | 4 | Product used for unknown indication |
| 125808252 | 12580825 | 5 | Product used for unknown indication |
| 125808252 | 12580825 | 6 | Product used for unknown indication |
| 125808252 | 12580825 | 7 | Product used for unknown indication |
| 125808252 | 12580825 | 8 | Product used for unknown indication |
| 125808252 | 12580825 | 9 | Product used for unknown indication |
| 125808252 | 12580825 | 10 | Product used for unknown indication |
| 125808252 | 12580825 | 11 | Constipation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125808252 | 12580825 | HO |
| 125808252 | 12580825 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125808252 | 12580825 | Constipation | |
| 125808252 | 12580825 | Dizziness | |
| 125808252 | 12580825 | Fatigue | |
| 125808252 | 12580825 | Haemoglobin decreased | |
| 125808252 | 12580825 | Presyncope |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125808252 | 12580825 | 1 | 20160503 | 0 | ||
| 125808252 | 12580825 | 2 | 20160503 | 0 |